Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
As economic pressures continue to increase and the ability to efficiently manage costs is emphasized, firms, organizations and agencies are on a constant search for the best deals on business essentials. IndyBar members now have the benefit of discounts on travel, office supplies, cellular devices and plans and much more through a new agreement with National Purchasing Partners (NPP), a group purchasing organization (GPO) created to leverage the purchasing power of a group of businesses to obtain discounts from world class vendors.
Cooperative purchasing allows smaller businesses to pool together under a negotiated contract and receive discounts based on their increased group purchasing power. Through NPP, IndyBar members can take advantage of steep discounts on a variety of purchases, helping firms of all sizes stretch dollars and create efficiencies. NPP’s strong reputation allows it to extend tier pricing from prominent national companies like Verizon, Expedia, Staples and Kimball Office to IndyBar members.
There are no fees for IndyBar members to utilize the NPP discount program, and the program requires no volume or minimum purchase commitments. IndyBar members select what, when and how much to purchase with no further obligation.
Beyond the legal industry, NPP also serves members in markets such as fire and rescue, health care, construction, hospitality, non-profit, government, oil and gas, transportation and agriculture. With more than 100,000 existing member companies representing millions of Americans, NPP is one of the largest and fastest growing GPOs in the nation.
The money you save makes a difference.
Founded in 2001 and headquartered in Seattle, NPP is owned by Virginia Mason Medical Center, a non-profit health care facility recently named the nation’s top hospital of the decade. NPP contributes to the medical center’s crucial initiatives, including research into cures for diabetes, arthritis, lupus, and multiple sclerosis. Since 2001, over $100 million has gone to major medical research and advancements.•
Please enable JavaScript to view this content.